Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Sight Sciences (SGHT) EBITDA Margin (2020 - 2025)

Historic EBITDA Margin for Sight Sciences (SGHT) over the last 6 years, with Q3 2025 value amounting to 39.71%.

  • Sight Sciences' EBITDA Margin rose 160000.0% to 39.71% in Q3 2025 from the same period last year, while for Sep 2025 it was 59.64%, marking a year-over-year increase of 28500.0%. This contributed to the annual value of 63.27% for FY2024, which is 73900.0% up from last year.
  • Sight Sciences' EBITDA Margin amounted to 39.71% in Q3 2025, which was up 160000.0% from 59.64% recorded in Q2 2025.
  • In the past 5 years, Sight Sciences' EBITDA Margin ranged from a high of 39.71% in Q3 2025 and a low of 149.14% during Q1 2022
  • In the last 5 years, Sight Sciences' EBITDA Margin had a median value of 79.16% in 2025 and averaged 85.74%.
  • As far as peak fluctuations go, Sight Sciences' EBITDA Margin soared by 1312300bps in 2021, and later plummeted by -443500bps in 2022.
  • Sight Sciences' EBITDA Margin (Quarter) stood at 100.21% in 2021, then grew by 17bps to 83.01% in 2022, then rose by 29bps to 59.25% in 2023, then dropped by -6bps to 62.54% in 2024, then skyrocketed by 37bps to 39.71% in 2025.
  • Its last three reported values are 39.71% in Q3 2025, 59.64% for Q2 2025, and 79.16% during Q1 2025.